UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000043448
Receipt number R000049615
Scientific Title A retrospective observational study of long-term prognosis and factors associated with long-term prognosis in patients admitted to the ICU
Date of disclosure of the study information 2021/03/01
Last modified on 2022/08/29 09:57:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A retrospective observational study of ICU admitted patients long-term prognosis and its related factors

Acronym

ICU admitted patients long-term prognosis study

Scientific Title

A retrospective observational study of long-term prognosis and factors associated with long-term prognosis in patients admitted to the ICU

Scientific Title:Acronym

ICU admitted patients long-term prognosis study

Region

Japan


Condition

Condition

ICU admitted patients

Classification by specialty

Intensive care medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

By now, evaluation of the effectiveness of treatment in the ICU focused on relatively short-term prognosis, such as survival rate in the ICU and survival rate at 28 days, but with advances in ICU treatment methods, attention has been focused on the long-term prognosis of patients in the ICU and factors related to that prognosis. It is also important to maintain ADL after ICU discharge. However, although there are some reports on these issues, they are still rare. The purpose of this study was to investigate the prognosis of patients admitted to the ICU at 6 and 12 months and to identify factors associated with long-term prognosis. Furthermore, by predicting the long-term prognosis before admission to the ICU, we aim to realize the appropriate use of the ICU.

Basic objectives2

Others

Basic objectives -Others

analysis of long-term prognosis and its related factors

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

ADL (Barthel score) at 6 months after the day of ICU admission

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

ICU admitted patients

Key exclusion criteria

age

Target sample size

3000


Research contact person

Name of lead principal investigator

1st name Masashi
Middle name
Last name Nakagawa

Organization

Tokyo Women's Medical University

Division name

Department of Intensive Care Medicine

Zip code

1628666

Address

8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666 Japan

TEL

03-3353-8111

Email

mnmanta@gmail.com


Public contact

Name of contact person

1st name Masashi
Middle name
Last name Nakagawa

Organization

Tokyo Women's Medical University

Division name

Department of Intensive Care Medicine

Zip code

1628666

Address

8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666 Japan

TEL

03-3353-8111

Homepage URL


Email

mnmanta@gmail.com


Sponsor or person

Institute

Tokyo Women's Medical University

Institute

Department

Personal name



Funding Source

Organization

Tokyo Women's Medical University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tokyo Women's Medical University

Address

8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666 Japan

Tel

03-3353-8111

Email

mnmanta@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 03 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

0

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2021 Year 02 Month 04 Day

Date of IRB

2021 Year 02 Month 09 Day

Anticipated trial start date

2021 Year 03 Month 01 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

none


Management information

Registered date

2021 Year 02 Month 26 Day

Last modified on

2022 Year 08 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049615


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name